Volume 16, Number 10—October 2010
Research
Risk Factors for Pandemic (H1N1) 2009 Virus Seroconversion among Hospital Staff, Singapore
Table 1
Characteristic |
No. (%) seroconverters, n = 35 |
No. (%) nonseroconverters, n = 496 |
p value |
Baseline sample timing | 0.20† | ||
Jun 22–26 | 17 (49) | 187 (38) | |
Jun 28–Jul 7 |
18 (51) |
309 (62) |
|
Follow-up samples taken | 0.73† | ||
Intraepidemic only | 3 (9) | 65 (13) | |
Postepidemic only | 2 (6) | 31 (6) | |
Intraepidemic and postepidemic |
30 (86) |
400 (81) |
|
Female |
30 (86) |
411 (83) |
0.66† |
Seasonal influenza vaccination | 34 (97) | 449 (91) | 0.19† |
ARI episode‡ | 22 (63) | 75 (15) | <0.01† |
FRI episode‡ |
18 (51) |
41 (8) |
<0.01† |
Age, y, mean (95% CI) | 35 (31–39) | 34 (33–35) | 0.76§ |
GMT for baseline sample (95% CI) | 5.9 (5.3–6.5) | 7.8 (7.3–8.3) | 0.02§ |
*ARI, acute respiratory illness; FRI, febrile respiratory illness; CI, confidence interval; GMT, geometric mean titer.
†χ2 test comparing seroconverters and nonseroconverters.
‡Healthcare workers who seroconverted are considered to have had an ARI or FRI episode if the date of onset preseded the date when seroconversion was detected.
§Student t test comparing seroconverters and nonseroconverters.
Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.